Oct 12, 2026 · 7 min
Starbucks rejects Chipotle deal as Salesforce rides AI optimism
Starbucks Denies Acquiring Chipotle, Bristol Myers Falls, Salesforce
The episode connects three market moves to deeper questions about turnaround capacity, clinical-trial interpretation, and whether enterprise software can withstand AI disruption.
- 1Starbucks denied acquiring Chipotle, raising questions about whether another turnaround would stretch its strategic capacity.
- 2Bristol Myers Squibb shares fell after lung-disease trial results produced an unexpected gap between lower- and higher-dose outcomes.
- 3Bank of America’s Salesforce upgrade frames embedded data and workflows as a defense against AI-driven platform disruption.
Don't miss
The Salesforce discussion turns AI from a disruption threat into a potential advantage because companies may resist abandoning platforms containing their data and workflows.
The brief
Chipotle shares fell after Starbucks denied acquisition rumors, prompting a broader question: could Starbucks absorb another turnaround while still repairing its own business?
Matthew Griffin provides market context as the discussion weighs the strategic logic of a Starbucks-Chipotle deal and the leadership challenges surrounding both restaurant companies.
Bristol Myers Squibb became the episode’s clearest case of confusing evidence: lung-disease trial results sent shares lower because the higher-dose outcome did not behave as expected.
Salesforce rallied after Bank of America upgraded the stock, arguing that AI could strengthen rather than undermine a platform woven into large companies’ data and workflows.